NFKB1 and lung cancer: NSCLC-derived EVs can also affect lung cancer progression directly by inducing a pro-inflammatory phenotype in mesenchymal stem cells via the NFκB-TLR pathway27, which promotes lung cancer growth, or indirectly by affecting the functions of immune cells in the tumor microenvironment28–30.